EMERGENT BIOSOLUTIONS INC. (EBS) Shareholders’ equity 2016–2025
EMERGENT BIOSOLUTIONS INC. (EBS) shareholders’ equity at each fiscal year-end, per SEC filings.
$522.6MFY2025 · since FY2016: $596.2M → $522.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $522.6M | +8.2% |
| FY2024 | $482.8M | -25.6% |
| FY2023 | $649.3M | -53.2% |
| FY2022 | $1.4B | -13.9% |
| FY2021 | $1.6B | +11.1% |
| FY2020 | $1.5B | +33.0% |
| FY2019 | $1.1B | +8.0% |
| FY2018 | $1.0B | +10.8% |
| FY2017 | $912.3M | +53.0% |
| FY2016 | $596.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice